Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

PDE IV/TNF production inhibitors claimed by Schering AG for MS

Jan. 14, 1998

No Comments

Nastech licenses nasal scopolamine to Schwarz

Jan. 14, 1998

No Comments

Synaptic and Gruenenthal initiate pain collaboration

Jan. 13, 1998

No Comments

Akzo patents benzylamines for depression

Jan. 13, 1998

No Comments

New muscarinic receptor modulators from Lilly

Jan. 13, 1998

No Comments

More dopamine receptor ligands from Merck & Co.

Jan. 12, 1998

No Comments

Neurogen describes D3 receptor-specific ligands

Jan. 12, 1998

No Comments

Chiroscience synthesizes new MMP/TNF-inhibitory agents

Jan. 12, 1998

No Comments

Merck discloses novel D4 receptor ligands

Jan. 9, 1998

No Comments

Ares-Serono's recombinant IFN-beta1a recommended for approval by CPMP for MS

Jan. 9, 1998

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

PDE IV/TNF production inhibitors claimed by Schering AG for MS

Nastech licenses nasal scopolamine to Schwarz

Synaptic and Gruenenthal initiate pain collaboration

Akzo patents benzylamines for depression

New muscarinic receptor modulators from Lilly

More dopamine receptor ligands from Merck & Co.

Neurogen describes D3 receptor-specific ligands

Chiroscience synthesizes new MMP/TNF-inhibitory agents

Merck discloses novel D4 receptor ligands

Ares-Serono's recombinant IFN-beta1a recommended for approval by CPMP for MS

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice

Neurology/psychiatric RSS

Neurology/psychiatric
RSS